Follow
Founded in 1989, Delorbis Pharmaceuticals Ltd as a leading branded generic pharmaceutical company, offers a broad portfolio of more than 100 pharmaceutical products. At DELORBIS, they are dedicated to offer a balanced portfolio of EU-approved branded generics in accordance to local therapeutic needs.
They are proud of expanding their activities in more than 35 markets in the Middle East, Africa, Far East and CIS. Through their global strategic partnerships, they have managed to acquire one of the strongest generic pipelines.
Today DELORBIS, through combination of marketing and sales efforts created strategies to ensure constant growth. They work together with their partners to identify product opportunities. At DELORBIS, they strongly believe in keeping the customers satisfied and providing them with pharmaceutical products at affordable price.
DELORBIS premises are located in Ergates Industrial Area, Lefkosia, Cyprus. The manufacturing site consists of two units and one dedicated cytotoxic unit. Production, Packaging, Quality Control, Quality Assurance, Development, Warehouse departments are in place in their modern facilities and are staffed with high caliber scientific personnel. DELORBIS uses state of the art equipment and technology and operates within full compliance with European-Good Manufacturing Practice (EU-GMP) Rules and Regulations. In this high quality standard environment, their company provides among others, Quality Control (QC) services and Contract-Manufacturing to world-leading pharmaceutical companies.
